Filing Details
- Accession Number:
- 0000950170-25-011327
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-30 21:10:56
- Reporting Period:
- 2025-01-28
- Accepted Time:
- 2025-01-30 21:10:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1812364 | Relay Therapeutics Inc. | RLAY | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1818261 | Thomas Catinazzo | C/O Relay Therapeutics, Inc. 399 Binney Street, 2Nd Floor Cambridge MA 02142 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-28 | 33,753 | $4.63 | 265,473 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-28 | 2,283 | $4.63 | 263,190 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-01-28 | 139,141 | $0.00 | 402,331 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-01-29 | 2,109 | $4.55 | 400,222 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-30 | 20,791 | $4.42 | 379,431 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 105,723 shares of restricted stock units ("RSUs") on January 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- Includes 185,775 shares underlying RSUs.
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
- Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock uponvesting.
- Includes 324,916 shares underlying RSUs.
- Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 69,570 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- Includes 255,346 shares underlying RSUs.
Billionaire Hedge Funds
